Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
What ifWhat if hydroxypropyl beta-cyclodextrin carries a hydrophobic active ingredient in the aqueous phase?
Claim language“a liquid oil”
The cyclodextrin cavity binds part of the active molecule while its hydrophilic exterior keeps the complex dispersed in water. Phospholipid vesicles form in the same aqueous phase, and the bound active exchanges with the free dissolved fraction.
1.1A cellulose network slows settling
What ifWhat if hydrated hydroxyethyl cellulose provides physical support for the vesicle dispersion?
Claim language“a solid oil”
Hydroxyethyl cellulose dissolves in the continuous water phase and increases its viscosity through polymer chain overlap. The higher viscosity slows settling of suspended particles and vesicle aggregates.
1.1Nonionic surfactants form vesicles
What ifWhat if a nonionic surfactant forms the vesicle membrane?
Claim language“a phospholipid”
Sorbitan monostearate and cholesterol form bilayers when a mixed film is hydrated above the surfactant transition temperature. The bilayers close into vesicles with aqueous interiors.
1.1Calcium alginate immobilizes vesicles
What ifWhat if a calcium alginate gel holds the vesicles in place?
Claim language“parts by weight of gelatin”
Preformed vesicles are dispersed in aqueous sodium alginate. Calcium ions crosslink the alginate chains into a hydrated network that restricts vesicle movement.
1.1Unloaded vesicles serve as controls
What ifWhat if the vesicles carry no active ingredient and serve as a physical stability control?
Claim language“an active ingredient”
The phospholipid is hydrated with buffer to form vesicles with buffer-filled interiors. Particle size and visible phase separation are tracked during storage to characterize the carrier dispersion.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Fragrance delivery in fabric rinse
A fabric rinse uses limonene as the fragrance ingredient in a dispersion of liquid oil, solid oil, phospholipid, gelatin, and water. The limonene dissolves in the warmed oil blend before the blend is dispersed with phospholipid in an aqueous gelatin phase under shear. The cooled dispersion enters the final rinse water, which distributes the fragrance over the fabric.
Component substitution
Rice bran wax as solid oil
Rice bran wax replaces the solid oil in a liposome dispersion containing liquid oil, phospholipid, gelatin, water, and a cosmetic pigment. The wax melts into the liquid oil, and the pigment disperses in the molten blend under agitation. The molten blend combines with a heated aqueous phospholipid and gelatin dispersion under rotor-stator shear, and the wax solidifies as the mixture cools.
Parameter or scale variation
Phased cooling in a jacketed vessel
A 20 L jacketed vessel holds a 10 L batch containing a liquid oil, a solid oil, phospholipid, gelatin, riboflavin, and water. After hot mixing, an overhead impeller keeps the dispersion circulating while the jacket cools the batch to 40 °C at 1 °C per minute. The jacket holds the batch at 40 °C for 10 minutes before cooling it to 25 °C at 0.5 °C per minute.
Combination with existing systems
Liposome dosing on a soap line
A liquid hand soap filling line includes a side tank containing a liposome dispersion of liquid oil, solid oil, phospholipid, gelatin, water, and fragrance. A metering pump feeds the dispersion into cooled soap base downstream of the main mixing tank. A static mixer distributes the dispersion through the soap immediately upstream of the bottle filler.
Liposome addition to starch film
A film casting line uses a liposome dispersion containing liquid oil, solid oil, phospholipid, gelatin, water, and beta-carotene. A low-shear mixer folds the dispersion into a cooked starch solution after the solution cools to 40 °C. A doctor blade spreads the mixture onto a moving belt, and forced air removes water to form a pigmented starch film.
Automated or data-driven variant
Particle size control during homogenization
A recirculating homogenizer processes a dispersion containing liquid oil, solid oil, phospholipid, gelatin, water, and riboflavin. A sidestream sampler dilutes aliquots at a fixed ratio and feeds them to a laser diffraction analyzer. The controller ends recirculation and starts jacket cooling after two consecutive measurements meet a preset upper limit for the volume-based 90th-percentile particle diameter.
Specific version of a part
Soybean oil in a lipid blend
The formulation contains 3 parts by weight of refined soybean oil. The oil is blended with the phospholipid and solid oil before the lipid phase is dispersed in water.
Palm stearin in the lipid phase
The formulation contains 6 parts by weight of palm stearin. The stearin is melted into the lipid blend before dispersion and crystallizes as the mixture cools.
Phosphatidylcholine in mixed lecithin
The formulation contains 15 parts by weight of lecithin with a phosphatidylcholine content of 50 percent by weight. Hydration assembles the bilayer-forming phospholipids into vesicles, and extrusion through a porous membrane narrows the size distribution.
Gelatin in the aqueous phase
The formulation contains 5 parts by weight of gelatin with a Bloom value of 250. The gelatin is dissolved in warm water before mixing with the lipid dispersion and forms a hydrated network on cooling.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.12 to 5 parts by weight of a liquid oil, 3 to 10 parts by weight of a solid oil, 5 to 30 parts by weight of a phospholipid, 3 to 10 parts by weight of gelatin, 1 to 7 parts by weight of an active ingredient, and 20 to 70 parts by weight of water.
In the liquid composition, the concentration of the water is between 50% by weight and 95% by weight, especially between 55% by weight and 75% by weight, and the concentration of the at least one organic solvent and preferably of the alcohol is between 5% by weight and 50% by weight, especially between 8% by weight and 25% by weight.
A · US 2013/0309215 A1 · ¶ 22
A liposomal formulation was developed having a molar ratio of 6:3:1 1,2-di-O-hexadecyl-sn-glycero-3-phosphatidylcholine, 1,2-di-O-phytanyl-sn-glycero-3-phosphatidylethanolamine, and DHA sodium salt (FIG. 1). These liposomes were made by drying the lipid solution and DHA sodium salt under nitrogen for four hours, followed by rehydration in one milliliter of 0.9% degassed saline solution.
B · US 10,272,041 B2 · ¶ 95
An empty cell means only that no passage was reproduced there.
Statements in these documents
The object of the present invention is to provide a pharmaceutical composition of the stated art, which has an especially high ability for permeation of pharmaceutical active ingredients.
A · US 2013/0309215 A1 · ¶ 5
Furthermore the inventive composition contains at least one phospholipid, which improves the transport of the active ingredient trough the cell membrane during a topical application of the inventive composition, whereby the phospholipid contains a concentration of phosphatidylcholine of at least 60% by weight referring to the total weight of the phospholipid (dry weight).
A · US 2013/0309215 A1 · ¶ 7
Thus, there is a need in the art for liposomes having the required stability for the oral delivery of a bioactive agent.
B · US 10,272,041 B2 · ¶ 4
These formulations allow for an increase in bioavailability of a bioactive agent, such as for example, stability of DHA in circulation and at the breast tissue leading to the prevention of breast cancer.
B · US 10,272,041 B2 · ¶ 5
Cite aspatent.fyi, US 2026/0355112 A1, claim 1, first published 2026-11-19T08:28:42-05:00, https://patent.fyi/US20260355112/, SHA-256 5831ee961ac865d558bef638430abf67ca079434186457b300433213f99fde2c